The CDC data shows the estimated biweekly prevalence of the most common SARS-CoV-2 lineages circulating in the U.S., based on more than 40,000 sequences collected through the agency’s national genomic surveillance since Dec 20.
For the weeks Jan. 3 to March 27, the CDC estimates these three variants each account for nearly 50 percent of all U.S. COVID-19 cases.
B.1.1.7 (first identified in U.K.): 44.1 percent
P.1 (first identified in Brazil): 1.4
B.1.351 (first identified in South Africa): 0.7
More articles on public health:
UK variant more transmissible, not deadlier, study finds
Hispanic Americans see highest COVID-19 hospitalization rates across US: 6 CDC findings
Unvaccinated teens, children driving COVID-19 surges
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.